Everything you need to know about the most important trend in the history of the world
Within most people's lifetimes, the developments in the biotechnology sector will allow us to live increasingly long and healthy lives, as well as provide us with technological innovations that will transform the way we live. But these innovations offer more than just hope for a better life, but hope for better returns too. Financial returns of incredible magnitude await savvy investors and businesspeople who can see the massive changes on the horizon. This book details these fast-moving trends and innovations and offers extensive advice on how to profit from them in business and investing.
By:
Jim Mellon (.),
Al Chalabi (.)
Imprint: John Wiley & Sons Inc
Country of Publication: United States
Dimensions:
Height: 224mm,
Width: 142mm,
Spine: 25mm
Weight: 553g
ISBN: 9781119963189
ISBN 10: 1119963184
Pages: 360
Publication Date: 13 April 2012
Audience:
Professional and scholarly
,
Undergraduate
Format: Hardback
Publisher's Status: Active
Acknowledgements ix Introduction xi Chapter One Transformational Technologies 1 Futurists and Scientists Look into the Future 1 The Convergence of Technology and Biology 13 Chapter Two The Evolution of Medicine and the Emergence of Biopharma 23 From Atoms to Cells to Living Organisms 24 The History of the Pharmaceutical Industry 36 Chapter Three The Drug Industry – Reinventing the Model 55 Big Pharma, Biopharma 59 Drug Patents 73 The Path to Riches: FDA Approval 79 In Summary 84 Chapter Four Curing Disease – Promising Prospects in the Main Therapeutic Areas 87 Cancer – Step by Step, Being Beaten 89 Infectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector 107 Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease 118 The Heart of the Matter – Biggest Killer on the Prowl 128 Fading into the Night – Neurodegeneration, Rheumatology and Multiple Sclerosis 132 Respiratory Disease – New Drugs: A Breath of Fresh Air 143 Rare Diseases and Rare Profits 146 Drugs for Pain and for the Central Nervous System 150 The Best of the Rest – Ophthalmology, Dermatology, Gastrointestinal and Bone Disease 153 Chapter Five Turning Back the Clock – Stem Cells, Genomics, Gene Therapy and Regeneration 157 Stem Cells 166 Gene Therapy and Nano Medicine 170 Organ Growth in and out of the Body 178 Chapter Six Demographic Changes 181 The Working Age Labour Pool in the World is Shrinking 191 Can Immigration Solve the Labour Shortage in the Developed World? 193 The Social Impact of an Ageing Population 195 The United States is the Best Positioned Developed Country 196 Support Ratios Have Been Plummeting 197 China’s Grey Future 198 What Can Governments Do To Avoid Their Country Becoming a Nursing Home? 200 Chapter Seven Bioscience’s Disruptive Influences 205 Insurance and Healthcare 206 Real Estate 210 Politics 211 Geopolitics 211 Retail Goods and Services 212 The Food Industry 213 The Investment Industry 214 The Law 215 Shortage of Young People in Developed Nations 217 Chapter Eight Robotics and Nanotechnology 219 Robotics 219 Surgical Procedures/Surgical Assistance 220 Medical Monitor/Nurse 223 Housemaid/Domestic Assistance 228 Companion/Pet 229 Nanotechnology 232 Chapter Nine Lifestyle Maintenance 235 It’s a Fact: Obesity Shortens Your Life 235 Extending Life Expectancy 237 Common Traits of People who Live the Longest 239 A “Cure” to Ageing 240 Telomeres – Our Biological Clock 244 Chapter Ten Investment in Biopharma – Chasing Those Money Fountains 247 Conservative Portfolio 279 Balanced Portfolio 280 Speculative Portfolio 281 Company Overviews 282 Summary 305 Glossary 315 Appendix – Key Financial Charts of Big Pharma 325 References 327 Bibliography 329 Index 331
JIM MELLON is an investor with interests in several industries. He is founder of a listed fund management company, Charlemagne Capital, and an Asian mining group, Regent Pacific. In addition, Jim is a director of Manx Financial Group – an Isle of Man based bank, and a controlling shareholder of Speymill – a property business, and Webis Holdings. He is a co-founder of Uramin and West African Minerals Resources, both mining groups. The Burnbrae Group, his private company, is a substantial landlord in Germany and in the Isle of Man, and he also owns the hotel chain Sleepwell Hotels. Jim spends most of his time working on start-up ideas and on investing. Jim lives in the Isle of Man, Brussels and Ibiza. He is an honorary fellow of Oriel College, Oxford. AL CHALABI is an entrepreneur with a diverse professional background who started his career as a systems engineer in Canada. Following this, he worked as a management consultant advising corporations across a number of industries, and more recently as the CFO for a real estate investment company. He currently runs CASP-R, a firm he co-founded in 2008 to provide independent real estate research and advisory services to investors and corporate occupiers across the Asia-Pacific region. He lives in Hong Kong with his partner Fiona and two young children.
